Más de 40 preguntas y respuestas acerca del nuevo coronavirus

Eric Martínez Torres

Texto completo:

PDF

Resumen

Cada paciente requiere una evaluación particular considerando criterios individuales de tipo clínicos y laboratoriales, así como epidemiológicos y sociales. Los protocolos chinos así lo expresaban: ¨el paciente ha tenido una respiración no alterada, conciencia clara, habla no afectada, dieta normal y temperatura corporal normal durante más de 3 días; las imágenes de pulmón muestran una mejora significativa;y dos pruebas consecutivas de ácido nucleico han sido negativas¨ (4). El seguimiento es mandatorio pues los pacientes que se han recuperado de COVID-19 pueden quedar con un daño permanente en sus pulmones, en específico con fibrosis pulmonar.

Referencias

REFERENCIAS BIBLIOGRAFICAS

- Freeman MC, DenisierMR. Coronavirus, en: Nelson Tratado de Pediatria 20ª. edición Kliegman RN, Stenton B, StGeme JW, Schor N, 264: 1691-93, Elsevier, 2016.

- Hamre D, Connell Jr P, Procknow JJ. Virologic studies of acute respiratory disease in young adults: IV. Virus. Isolations during four years of surveillance. Amer J Epidemiol 83: 238–249, Issue 2, March 1966, https://doi.org/10.1093/oxfordjournals.aje.a120579. Published: 01 March 1966

- Diangeng Li D; Jin M, Bao P, Zhao W, Zhang X,

Clinical Characteristics and Results of Semen Tests Among MenWith Coronavirus Disease 2019

JAMA Network Open. 2020;3(5):e208292. doi:10.1001/jamanetworkopen.2020.8292

- Gandhi M, Yokoe DS, Diane V. Havlir DV. Asymptomatic transmission: the Achilles’ Heel of Current Strategies to Control Covid-19. NEJMe2009758, April 24, 2020 . DOI: 10.1056/

- CONSEJOS BASADOS EN LA CIENCIA DEL MANUAL DE PREVENCIÓN DE CORONAVIRUS QUE PODRÍAN SALVAR SU VIDA. Editor Jefe Wang Zhou, MD. Copyright © 2020 Hubei Science and Technology Press Wuhan, China

- Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-infected Pneumonia in Wuhan, China. JAMA. 2020 Feb 7. doi: 10.1001/jama.2020.1585. [Epub ahead of print]

- Schwartz DA. An Analysis of 38 Pregnant Women with COVID-19, their Newborn Infants, and Maternal-Fetal Transmission of SARS-CoV-2: Maternal Coronavirus Infections and Pregnancy Outcomes. Arch Pathol Lab Med. 2020 Mar 17. doi: 10.5858/arpa.2020-0901-SA. [Epub ahead of print.

- Zeng L; Xia S, Yuan W, et al. Neonatal Early-Onset Infection With SARS-CoV-2 in 33 Neonates Born to Mothers With COVID-19 in Wuhan, China.JAMA Pediatr. Published online March 26, 2020. doi:10.1001/jamapediatrics.2020.0878 Se escribe et al a partir de más de 6 autores

- Ye Q, Wang B, Mao J. The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19. Journal of Infection. JID: YJINF [m5G; April 13, 2020;©2020 The British Infection Association. Published by Elsevier Ltd.

- Madjid, M, Safavi-Naeini P,. Solomon SD, Vardeny O, Potential Effects of Coronaviruses on the Cardiovascular System. A Review.JAMA Cardiol. doi:10.1001/jamacardio.2020.1286

- Mao L, Jin H,Wang M. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurol. April 10, 2020

- Li YC, Bai WZ, Hashikawa T. The Neuroinvasive Potential of SARS-CoV2 May Play a Role in the Respiratory Failure of COVID-19 Patients. J Med Virol 2020 Feb 27[Online ahead of print)

- Buja LM, Wolf DA , Zhao B, Akkanti B, McDonald M et al. The emerging spectrum of cardiopulmonary pathology of the coronavirus disease 2019 (COVID-19). Cardiovascular Pathology 48 (2020) 107233

- Dong Y, Mo X, Hu Y, et al .Epidemiology of COVID-19 among children in China. Pediatrics

;e20200702. 10.1542/peds.2020-0702 32179660Se escribe et al a partir de más de 6 autores

- Shekerdenian LS et al. Characteristics and Outcomes of Children With Coronavirus Disease 2019 (COVID-19) Infection Admitted to US and Canadian Pediatric Intensive Care Units. Published Online: May 11, 2020. doi:10.1001/jamapediatrics.2020.1948 Se escribe et al a partir de más de 6 autores

- Watson J, Brush JE. Interpreting a covid-19 test result. BMJ 2020;369:m1808 doi: 10.1136/bmj.m1808 (Published 12 May 2020

- Balanchadar V, MahalaxmiI, KaavyaJ, Vivedkanandhan G, Ajithkumar S, Arul, Net al. COVID-19: emerging protective measures. European Review for Medical and Pharmacological Sciences 2020; 24: 3422-3425

- She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. ClinTransl Med. 2020 Feb 20;9(1):19. doi: 10.1186/s40169-020-00271-z

- Chu CM. Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings. Thorax2004; 59: 252–56.

- Falzarano D, de Wit E, Rasmussen AL, et al. Interferon-α2b and ribavirin treatment improves outcome in MERS-CoV-infected rhesus macaques. Nat Med. 2013;19(10):1313–1317. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4093902/ Se escribe et al a partir de más de 6 autores

- Calvo C, et al. Recomendaciones sobre el manejo clínico de la infección por el «nuevo coronavirus» SARS-CoV2. Grupo de trabajo de la Asociación Española de Pediatría (AEP). AnPediatr (Barc). 2020. https://doi.org/10.1016/j.anpedi.2020.02.001

Igual que la anterior

- Chen ZM, Fu JF, Shu Q, Chen YH, Hua CZ, Li FB, et al. Diagnosis and treatment recommendations for pediatric respiratory infection caused by the 2019 novel coronavirus. World Journal of Pediatrics - https://doi.org/10.1007/s12519-020-00345-5

- Yao X, Ye F, Zhang M, Cui C, Huang B, Niu P, et al. In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Clin Infect Dis.2020 Mar 9. [Medline].

- Goo J, Tian Z, Yang X. Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies. Biosci Trends. 2020 Feb 19. [Medline].

- West M et al. Heparin inhibits cellular invasion by SARS-CoV-2: structural dependence of the interaction of the surface protein (spike) S1 receptor binding domain with heparin. https://doi.org/10.1101/2020.04.28.066761 Se escribe et al a partir de más de 6 autores

- WHO. Clinical management of severe acute respiratory infection when novel coronavirus (nCoV) infection is suspected. Jan 11, 2020. https://www.who.int/internal-publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected (accessed Jan 19, 2020).

- Arabio YM, Mandourah Y, Al-Hameed F, et al. Corticosteroid therapy for critically ill patients with Middle East respiratory syndrome. Am J RespirCrit Care Med 2018; 197: 757–67

.

.

Enlaces refback

  • No hay ningún enlace refback.




Copyright (c) 2020 Eric Martínez Torres

Licencia de Creative Commons
Este obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial 4.0 Internacional.